Fed. Circ. Panel Doubts Bid To Nix Actavis' $12M Deduction

By Anna Scott Farrell · June 7, 2024, 1:56 PM EDT

A Federal Circuit panel seemed skeptical of the government's bid to overturn a decision allowing drugmaker Actavis to deduct $12 million it spent fending off lawsuits as it secured approval to...

To view the full article, register now.